Back to Project List

Applying Optical Pooled Screens to Identify New Therapeutic Targets


Award Collaborative Pairs Pilot Project Awards (2020)
Disease ALS

Project Description

This project aims to develop an innovative platform for the discovery of new therapeutic targets in neurodegenerative diseases by applying optical genetic screens in patient fibroblasts and human neurons. The team takes advantage of a new method developed by the Blainey lab for a microscopy-based screen in human iPSC cells that links specific cellular phenotypes with in situ sequencing. They will use this platform to identify new genes and pathways for ALS. Since this new technology has not been previously deployed in neurodegenerative diseases, this project could potentially be readily applied to other neurodegenerative diseases.


Investigators

Paul C. Blainey
Paul C. Blainey
Clotilde Lagier-Tourenne
Clotilde Lagier-Tourenne